CN Stock MarketDetailed Quotes

JiangXi Tianxin Pharmaceutical (603235)

Watchlist
  • 25.94
  • +0.14+0.54%
Market Closed May 6 15:00 CST
11.36BMarket Cap21.84P/E (TTM)

JiangXi Tianxin Pharmaceutical (603235) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
3.37%639.76M
6.18%2.35B
1.08%1.63B
5.23%1.12B
25.16%618.91M
17.35%2.21B
8.49%1.61B
-4.81%1.07B
-14.46%494.5M
-18.34%1.88B
Operating revenue
3.37%639.76M
6.18%2.35B
1.08%1.63B
5.23%1.12B
25.16%618.91M
17.35%2.21B
8.49%1.61B
-4.81%1.07B
-14.46%494.5M
-18.34%1.88B
Other operating revenue
----
-18.78%22.74M
----
-11.09%12.82M
----
-8.51%28M
----
-20.90%14.41M
----
-40.82%30.6M
Total operating cost
27.79%475.32M
13.60%1.67B
4.50%1.11B
5.92%710.91M
12.87%371.95M
8.38%1.47B
1.35%1.06B
-9.95%671.17M
-27.47%329.54M
-17.19%1.36B
Operating cost
23.64%383.91M
5.63%1.35B
-4.31%891.45M
-5.26%585.51M
4.78%310.5M
10.24%1.28B
-1.08%931.58M
-12.49%618M
-25.16%296.34M
-19.71%1.16B
Operating tax surcharges
121.26%10.74M
25.51%28.52M
28.48%20.48M
13.39%11.42M
-5.61%4.85M
14.74%22.73M
4.35%15.94M
3.48%10.07M
25.85%5.14M
-9.84%19.81M
Operating expense
18.77%10.33M
13.26%37.2M
9.41%26.95M
16.45%19.85M
181.57%8.69M
-0.04%32.85M
8.33%24.63M
7.59%17.04M
-44.25%3.09M
7.05%32.86M
Administration expense
10.68%39.13M
25.49%180.92M
24.77%123.48M
32.69%77.51M
26.57%35.36M
5.74%144.17M
-4.79%98.97M
-8.27%58.41M
-14.01%27.93M
-5.43%136.35M
Financial expense
229.26%10.58M
77.02%-25.3M
67.41%-27.94M
66.62%-25.84M
68.19%-8.18M
-7.46%-110.07M
16.24%-85.74M
12.58%-77.41M
-12,866.80%-25.73M
-13.09%-102.43M
-Interest expense (Financial expense)
62.51%9.94M
106.47%8.16M
96.52%5.47M
92.84%3.97M
--6.12M
88.13%3.95M
--2.78M
299.85%2.06M
----
-69.69%2.1M
-Interest Income (Financial expense)
48.44%-7.35M
37.01%-37.39M
46.82%-27.28M
60.55%-17.48M
41.15%-14.26M
20.28%-59.36M
---51.3M
-33.63%-44.31M
-99.07%-24.23M
-358.17%-74.46M
Research and development
-0.44%20.63M
-3.17%100.52M
-1.91%71.32M
-5.74%42.46M
-9.01%20.72M
-7.28%103.82M
16.03%72.72M
17.25%45.05M
41.75%22.77M
25.15%111.96M
Credit Impairment Loss
4.04%-749.26K
87.82%-421.8K
254.25%2.92M
139.52%1.04M
66.88%-780.79K
-209.63%-3.46M
-129.49%-1.89M
-227.63%-2.64M
-344.43%-2.36M
-2.30%3.16M
Asset Impairment Loss
----
-129.92%-17.34M
-167.70%-14M
-167.71%-14M
----
38.99%-7.54M
-472.13%-5.23M
-472.13%-5.23M
----
-197.36%-12.36M
Other net revenue
-4.35%12.38M
-12.62%34.96M
-13.01%28.06M
-16.19%13.79M
13.42%12.94M
-1.20%40.01M
-32.17%32.26M
2.25%16.45M
64.24%11.41M
-36.20%40.49M
Fair value change income
----
----
--465.54K
--465.54K
---2.21M
--2.24M
----
----
----
----
Invest income
-54.90%1.72M
63.97%8.93M
68.62%6.16M
1,029.45%4.12M
947.66%3.82M
162.43%5.44M
144.45%3.65M
-69.06%364.87K
6.51%364.87K
-68.72%2.07M
-Including: Investment income associates
----
----
----
----
----
93.38%-25.15K
----
----
----
-299.01%-379.69K
Asset deal income
----
-52,594.35%-505.17K
-1,169.94%-10.3K
---10.3K
---407.12
--962.33
--962.33
----
----
----
Other revenue
-5.82%11.4M
2.24%44.3M
-8.96%32.53M
-7.47%22.17M
-9.65%12.11M
-9.01%43.33M
-11.88%35.73M
74.21%23.96M
87.85%13.4M
-10.87%47.62M
Operating profit
-31.97%176.82M
-8.92%705.31M
-5.87%553.26M
3.24%425.23M
47.37%259.9M
37.73%774.36M
19.72%587.74M
5.26%411.9M
34.91%176.37M
-22.53%562.22M
Add:Non operating Income
-65.17%28.43K
81.57%1.93M
2,239.15%969.83K
1,269.70%438.11K
482.12%81.61K
-82.45%1.06M
303.64%41.46K
4,280.65%31.99K
--14.02K
89.98%6.05M
Less:Non operating expense
38.65%98.25K
-22.68%2.82M
-7.54%2.59M
-42.22%1.08M
-89.00%70.86K
17.78%3.64M
62.25%2.8M
296.38%1.87M
705.13%644.1K
-0.82%3.09M
Total profit
-32.00%176.75M
-8.73%704.42M
-5.70%551.65M
3.54%424.59M
47.90%259.92M
36.56%771.77M
19.58%584.98M
4.92%410.06M
34.51%175.74M
-22.13%565.17M
Less:Income tax cost
-28.06%29.74M
-6.39%112.84M
0.93%91.34M
5.67%68.58M
46.69%41.35M
34.97%120.55M
18.60%90.5M
6.59%64.9M
27.82%28.19M
-13.82%89.32M
Net profit
-32.74%147M
-9.16%591.58M
-6.91%460.3M
3.14%356.01M
48.13%218.57M
36.85%651.22M
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
Net profit from continuing operation
-32.74%147M
-9.16%591.58M
-6.91%460.3M
3.14%356.01M
48.13%218.57M
36.85%651.22M
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
Net profit of parent company owners
-32.74%147M
-9.16%591.58M
-6.91%460.3M
3.14%356.01M
48.13%218.57M
36.85%651.22M
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
Earning per share
Basic earning per share
-32.00%0.34
-9.40%1.35
-6.19%1.06
3.80%0.82
47.06%0.5
36.70%1.49
20.21%1.13
5.33%0.79
36.00%0.34
-27.81%1.09
Diluted earning per share
-32.00%0.34
-9.40%1.35
-6.19%1.06
3.80%0.82
47.06%0.5
36.70%1.49
20.21%1.13
5.33%0.79
36.00%0.34
-27.81%1.09
Other composite income
Total composite income
-32.74%147M
-9.16%591.58M
-6.91%460.3M
3.14%356.01M
48.13%218.57M
36.85%651.22M
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
Total composite income of parent company owners
-32.74%147M
-9.16%591.58M
-6.91%460.3M
3.14%356.01M
48.13%218.57M
36.85%651.22M
19.76%494.48M
4.61%345.17M
35.87%147.55M
-23.51%475.85M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 3.37%639.76M6.18%2.35B1.08%1.63B5.23%1.12B25.16%618.91M17.35%2.21B8.49%1.61B-4.81%1.07B-14.46%494.5M-18.34%1.88B
Operating revenue 3.37%639.76M6.18%2.35B1.08%1.63B5.23%1.12B25.16%618.91M17.35%2.21B8.49%1.61B-4.81%1.07B-14.46%494.5M-18.34%1.88B
Other operating revenue -----18.78%22.74M-----11.09%12.82M-----8.51%28M-----20.90%14.41M-----40.82%30.6M
Total operating cost 27.79%475.32M13.60%1.67B4.50%1.11B5.92%710.91M12.87%371.95M8.38%1.47B1.35%1.06B-9.95%671.17M-27.47%329.54M-17.19%1.36B
Operating cost 23.64%383.91M5.63%1.35B-4.31%891.45M-5.26%585.51M4.78%310.5M10.24%1.28B-1.08%931.58M-12.49%618M-25.16%296.34M-19.71%1.16B
Operating tax surcharges 121.26%10.74M25.51%28.52M28.48%20.48M13.39%11.42M-5.61%4.85M14.74%22.73M4.35%15.94M3.48%10.07M25.85%5.14M-9.84%19.81M
Operating expense 18.77%10.33M13.26%37.2M9.41%26.95M16.45%19.85M181.57%8.69M-0.04%32.85M8.33%24.63M7.59%17.04M-44.25%3.09M7.05%32.86M
Administration expense 10.68%39.13M25.49%180.92M24.77%123.48M32.69%77.51M26.57%35.36M5.74%144.17M-4.79%98.97M-8.27%58.41M-14.01%27.93M-5.43%136.35M
Financial expense 229.26%10.58M77.02%-25.3M67.41%-27.94M66.62%-25.84M68.19%-8.18M-7.46%-110.07M16.24%-85.74M12.58%-77.41M-12,866.80%-25.73M-13.09%-102.43M
-Interest expense (Financial expense) 62.51%9.94M106.47%8.16M96.52%5.47M92.84%3.97M--6.12M88.13%3.95M--2.78M299.85%2.06M-----69.69%2.1M
-Interest Income (Financial expense) 48.44%-7.35M37.01%-37.39M46.82%-27.28M60.55%-17.48M41.15%-14.26M20.28%-59.36M---51.3M-33.63%-44.31M-99.07%-24.23M-358.17%-74.46M
Research and development -0.44%20.63M-3.17%100.52M-1.91%71.32M-5.74%42.46M-9.01%20.72M-7.28%103.82M16.03%72.72M17.25%45.05M41.75%22.77M25.15%111.96M
Credit Impairment Loss 4.04%-749.26K87.82%-421.8K254.25%2.92M139.52%1.04M66.88%-780.79K-209.63%-3.46M-129.49%-1.89M-227.63%-2.64M-344.43%-2.36M-2.30%3.16M
Asset Impairment Loss -----129.92%-17.34M-167.70%-14M-167.71%-14M----38.99%-7.54M-472.13%-5.23M-472.13%-5.23M-----197.36%-12.36M
Other net revenue -4.35%12.38M-12.62%34.96M-13.01%28.06M-16.19%13.79M13.42%12.94M-1.20%40.01M-32.17%32.26M2.25%16.45M64.24%11.41M-36.20%40.49M
Fair value change income ----------465.54K--465.54K---2.21M--2.24M----------------
Invest income -54.90%1.72M63.97%8.93M68.62%6.16M1,029.45%4.12M947.66%3.82M162.43%5.44M144.45%3.65M-69.06%364.87K6.51%364.87K-68.72%2.07M
-Including: Investment income associates --------------------93.38%-25.15K-------------299.01%-379.69K
Asset deal income -----52,594.35%-505.17K-1,169.94%-10.3K---10.3K---407.12--962.33--962.33------------
Other revenue -5.82%11.4M2.24%44.3M-8.96%32.53M-7.47%22.17M-9.65%12.11M-9.01%43.33M-11.88%35.73M74.21%23.96M87.85%13.4M-10.87%47.62M
Operating profit -31.97%176.82M-8.92%705.31M-5.87%553.26M3.24%425.23M47.37%259.9M37.73%774.36M19.72%587.74M5.26%411.9M34.91%176.37M-22.53%562.22M
Add:Non operating Income -65.17%28.43K81.57%1.93M2,239.15%969.83K1,269.70%438.11K482.12%81.61K-82.45%1.06M303.64%41.46K4,280.65%31.99K--14.02K89.98%6.05M
Less:Non operating expense 38.65%98.25K-22.68%2.82M-7.54%2.59M-42.22%1.08M-89.00%70.86K17.78%3.64M62.25%2.8M296.38%1.87M705.13%644.1K-0.82%3.09M
Total profit -32.00%176.75M-8.73%704.42M-5.70%551.65M3.54%424.59M47.90%259.92M36.56%771.77M19.58%584.98M4.92%410.06M34.51%175.74M-22.13%565.17M
Less:Income tax cost -28.06%29.74M-6.39%112.84M0.93%91.34M5.67%68.58M46.69%41.35M34.97%120.55M18.60%90.5M6.59%64.9M27.82%28.19M-13.82%89.32M
Net profit -32.74%147M-9.16%591.58M-6.91%460.3M3.14%356.01M48.13%218.57M36.85%651.22M19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M
Net profit from continuing operation -32.74%147M-9.16%591.58M-6.91%460.3M3.14%356.01M48.13%218.57M36.85%651.22M19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M
Net profit of parent company owners -32.74%147M-9.16%591.58M-6.91%460.3M3.14%356.01M48.13%218.57M36.85%651.22M19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M
Earning per share
Basic earning per share -32.00%0.34-9.40%1.35-6.19%1.063.80%0.8247.06%0.536.70%1.4920.21%1.135.33%0.7936.00%0.34-27.81%1.09
Diluted earning per share -32.00%0.34-9.40%1.35-6.19%1.063.80%0.8247.06%0.536.70%1.4920.21%1.135.33%0.7936.00%0.34-27.81%1.09
Other composite income
Total composite income -32.74%147M-9.16%591.58M-6.91%460.3M3.14%356.01M48.13%218.57M36.85%651.22M19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M
Total composite income of parent company owners -32.74%147M-9.16%591.58M-6.91%460.3M3.14%356.01M48.13%218.57M36.85%651.22M19.76%494.48M4.61%345.17M35.87%147.55M-23.51%475.85M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More